Skip to main content
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.550
+0.030 (1.19%)
At close: Jul 19, 2024, 4:30 PM
2.600
+0.050 (1.96%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

Oramed Pharmaceuticals Revenue

Oramed Pharmaceuticals had revenue of $674.00K in the twelve months ending March 31, 2024. In the year 2023, Oramed Pharmaceuticals had annual revenue of $1.34M.

Revenue (ttm)
$674.00K
Revenue Growth
-75.06%
P/S Ratio
153.71
Revenue / Employee
$51,846
Employees
13
Market Cap
103.60M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M--
Aug 31, 20212.70M-7.00K-0.26%
Aug 31, 20202.71M7.00K0.26%
Aug 31, 20192.70M254.00K10.37%
Aug 31, 20182.45M-7.00K-0.29%
Aug 31, 20172.46M1.82M283.15%
Aug 31, 2016641.00K--
Aug 31, 20150--
Aug 31, 20140--
Aug 31, 20130--
Aug 31, 20120--
Aug 31, 20110--
Aug 31, 20100--
Aug 31, 20090--
Aug 31, 20080--
Aug 31, 20070--
Aug 31, 20060--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
So-Young International 209.20M
FibroGen 167.49M
InterCure 97.95M
Omega Therapeutics 4.94M
VistaGen Therapeutics 1.06M
Cardiff Oncology 610.00K
Revenue Rankings

ORMP News

More News